Search For "controller"
DCGI to brief media today on COVID-19 vaccine
Updated : 5 years, 2 months ago IST
New Delhi [India], January 3 (ANI): The Drugs Controller General of India will brief the media at 11 am today at the National Media Centre regarding the coronavirus vaccine.
Read More
Recommendation for DCGI nod for restricted emergency use of two COVID-19 v
Updated : 5 years, 2 months ago IST
New Delhi [India], January 2 (ANI): With an expert panel of Drugs Controller General of India (DCGI) recommending grant of restricted emergency use authorisation to Bharat Biotech's indigenously developed COVID-19 vaccine on Saturday, doctors said it was a good development as the vaccine i
Read More
COVID-19: Expert committee recommends restricted emergency use of SII, Bha
Updated : 5 years, 2 months ago IST
New Delhi [India], January 2 (ANI): The Subject Expert Committee (SEC) of Central Drugs Standards Control Organisation on Saturday made recommendations to the Drugs Controller General of India to grant permission for restricted emergency use of SII, Bharat Biotech's vaccines.
Read More
Expert panel recommends restricted emergency use nod to Bharat Biotech's C
Updated : 5 years, 2 months ago IST
New Delhi [India], January 2 (ANI): An expert panel of Drugs Controller General of India (DCGI) has recommended granting restricted emergency use authorisation to Bharat Biotech's indigenously developed COVID-19 vaccine, also known as Covaxin, government sources told ANI on Saturday.
Read More
Urdu Bulletin: Expert panel grants emergency use authorisation for vaccine
Updated : 5 years, 2 months ago IST
New Delhi [India], January 2 (ANI): Various editions of Urdu publications have carried the prominent news that the Subject Expert Committee of Drugs Controller General of India (DCGI) has recommended granting permission for Emergency Use Authorisation (EUA) with certain conditions to COVID-1
Read More
Panel recommends to DCGI to grant emergency use authorisation to Serum's C
Updated : 5 years, 2 months ago IST
New Delhi [India], January 1 (ANI) In a major development related to the COVID vaccine, the Subject Expert Committee of Drugs Controller General of India (DCGI) has recommended granting permission for Emergency Use Authorisation (EUA)with certain conditions to COVID-19 vaccine being manufact
Read More
Expert committee to consider SII's emergency use approval for COVID-19 vac
Updated : 5 years, 2 months ago IST
New Delhi [India], December 30 (ANI): Subject Expert Committee (SEC) of Drugs Controller of India will take a meeting to consider Serum Institute of India's application for emergency use approval of its COVID-19 vaccine, says a government official.
Read More
Special Postal Cover released to commemorate 25 years of CDA in Secunderab
Updated : 5 years, 2 months ago IST
Secunderabad (Telangana) [India], December 22 (ANI): On successful completion of 25 years by the Controller of Defence Accounts (CDA), Secunderabad in service to Services, a 'Special Postal Cover' was released by S Rajendra Kumar, Indian Police Service (IPS), Chief Postmaster General, Telang
Read More
Six vaccines currently undergoing clinical trials in India
Updated : 5 years, 3 months ago IST
New Delhi [India], December 15 (ANI): Informing that the Drugs Controller General of India has granted clearance for the clinical trials of one more candidate vaccine from India, NITI Aayog Member (Health) Dr VK Paul on Tuesday said six vaccines are currently undergoing clinical trials in
Read More
Indigenous mRNA vaccine candidate supported by DBT gets Drug Controller no
Updated : 5 years, 3 months ago IST
New Delhi [India], December 11 (ANI): In a major development in the fight against COVID-19, India's first indigenous mRNA vaccine candidate has received approval from Indian Drug regulators to initiate Phase I/II human clinical trial.
Read More
DCGI expert panel asks SII, Bharat Biotech to provide more safety, efficac
Updated : 5 years, 3 months ago IST
New Delhi[India], December 9 (ANI): In a major development related to COVID-19 vaccine, Subject Expert Committee (SEC) of Drugs Controller General of India (DCGI) has asked for more safety and efficacy data from Serum Institute of India (SII) and Bharat Biotech for their COVID-19 vaccines
Read More
Reports that Centre rejected SII, Bharat Biotech's emergency use authorisa
Updated : 5 years, 3 months ago IST
New Delhi [India], December 9 (ANI): The Ministry of Health and Family Welfare on Wednesday dismissed the media report about the rejection of Serum Institute India (SII) and Bharat Biotech's emergency use authorisation of COVID vaccine and called it "fake".
Read More